ACTRN12623001328662招募中2 期
An Open-Label, Single-Arm, 2-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- RBP4 Pty Ltd
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 12 Years 至 20 Years（—）
- 性别
- All
入选标准
- •Subject has completed treatment in LBS-008-CT02 trial and has also completed the tests and assessments required end-of-treatment visit.
排除标准
- •1.Ocular surgery in the study eye in the previous 3 months.
- •2.Use of prescription medications such as Isotretinoin (13-cis-retinoic acid) or other retinol modulators or derivatives
- •3.Use of any known drugs or supplements that are moderate or strong inhibitors/inducers of cytochrome P450 (CYP) enzymes
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate if macitentan is safe and tolerable enough to be usedfor treatment of idiopathic pulmonary fibrosis, following the MUSICstudyEUCTR2010-024211-13-ESACTELION Pharmaceuticals Ltd.178
进行中（未招募）
1 期
ong-term study to evaluate if macitentan is safe, tolerable and efficient enough to be used for treatment of Eisenmenger syndromeMedDRA version: 17.1Level: PTClassification code 10058554Term: Eisenmenger's syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEisenmenger SyndromeEUCTR2012-004411-31-ROActelion Pharmaceuticals Ltd.217
进行中（未招募）
1 期
ong-term study to evaluate if macitentan is safe, tolerable and efficient enough to be used for treatment of Eisenmenger syndromeMedDRA version: 18.1 Level: LLT Classification code 10058554 Term: Eisenmenger's syndrome System Organ Class: 100000004850Eisenmenger SyndromeEUCTR2012-004411-31-PTActelion Pharmaceuticals Ltd217
进行中（未招募）
不适用
Study to evaluate if macitentan is safe and tolerable enough to be used for treatment of idiopathic pulmonary fibrosis, following the MUSIC studyPatients with Idiopathic Pulmonary FibrosisMedDRA version: 13.1Level: PTClassification code 10021240Term: Idiopathic pulmonary fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-024211-13-DEACTELION Pharmaceuticals Ltd.178
进行中（未招募）
1 期
ong-term study to evaluate if macitentan is safe, tolerable and efficient enough to be used for treatment of Eisenmenger syndromeEisenmenger SyndromeEUCTR2012-004411-31-PLActelion Pharmaceuticals Ltd.220